Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery

Ewart, L (author)

Dehne, EM (author)

Fabre, K (author)

Gibbs, S (author)

Hickman, J (author)

Hornberg, E (author)

Jang, KJ (author)

Jones, DR (author)

Marx, U (author)

Mettetal, JT (author)

Pointon, A (author)

Williams, D (author)

Zimmermann, WH (author)

Newham, P (author)

Insel, PA (author)

(creator_code:org_t)

Annual Reviews, 2018
2018
English.
In: Annual review of pharmacology and toxicology. - : Annual Reviews. - 1545-4304 .- 0362-1642. ; 58, s. 65-82

Related links:: http://kipublication...; show more...; https://doi.org/10.1...; show less...

Abstract Subject headings

Enhancing the early detection of new therapies that are likely to carry a safety liability in the context of the intended patient population would provide a major advance in drug discovery. Microphysiological systems (MPS) technology offers an opportunity to support enhanced preclinical to clinical translation through the generation of higher-quality preclinical physiological data. In this review, we highlight this technological opportunity by focusing on key target organs associated with drug safety and metabolism. By focusing on MPS models that have been developed for these organs, alongside other relevant in vitro models, we review the current state of the art and the challenges that still need to be overcome to ensure application of this technology in enhancing drug discovery.

By the author/editor: Ewart, L; Dehne, EM; Fabre, K; Gibbs, S; Hickman, J; Hornberg, E; show more...; Ingelman-Sundber ...; Jang, KJ; Jones, DR; Lauschke, VM; Marx, U; Mettetal, JT; Pointon, A; Williams, D; Zimmermann, WH; Newham, P; Insel, PA; show less...

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.